Capacity Bio

Capacity Bio is a clinical-stage biotechnology company developing mitophagy therapeutics to restore mitochondrial quality control in age- and disease-related conditions. Its platform advances small molecules, peptides, and nanoparticles that enhance identification and clearance of dysfunctional mitochondria. With operations in Los Angeles and Tokyo, the company closed a $35M financing round in 2023 and is backed by Insight Partners. As a drug-development firm, Capacity Bio publishes no public API, developer platform, or SDK surface; this profile is maintained in the API Evangelist network as a company record.

Capacity Bio is profiled on the APIs.io network. Tagged areas include Company, Biotech Therapeutics, Mitophagy, Mitochondrial Biology, and Drug Development.

🌐 Visit website 📡 Source on GitHub

6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotech TherapeuticsMitophagyMitochondrial BiologyDrug DevelopmentTherapeuticsBiotechnology

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 6.8/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/capacity-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: capacity-bio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/capacity-bio.png
name: Capacity Bio
description: Capacity Bio is a clinical-stage biotechnology company developing mitophagy therapeutics to restore mitochondrial
  quality control in age- and disease-related conditions. Its platform advances small molecules, peptides, and nanoparticles
  that enhance identification and clearance of dysfunctional mitochondria. With operations in Los Angeles and Tokyo, the company
  closed a $35M financing round in 2023 and is backed by Insight Partners. As a drug-development firm, Capacity Bio publishes
  no public API, developer platform, or SDK surface; this profile is maintained in the API Evangelist network as a company
  record.
url: https://raw.githubusercontent.com/api-evangelist/capacity-bio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotech Therapeutics
- Mitophagy
- Mitochondrial Biology
- Drug Development
- Therapeutics
- Biotechnology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://capacitybio.com/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence